PTCH1 and chronic myelogenous leukemia, BCR-ABL1 positive: Taken together, our findings that the PTCH1 measurement performed well in a largely different cohort extracted from secondary and tertiary hospitals with IF, progression, and CML-related death rates more similar to a real scenario adds external validity to previous results and suggests that the PTCH1 measurement is a reliable prognostic test.